Partner Headlines - BCRX

  1. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  2. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  3. Biotechs That Might Benefit From Ebola

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Stocks Hitting 52-Week Highs

    Benzinga
  6. Benzinga's Top Initiations

    Benzinga
  7. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  8. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  9. Ebola Stocks Continue Higher

    Benzinga
  10. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  11. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  12. Benzinga's Top Initiations

    Benzinga
  13. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Benzinga's Top Downgrades

    Benzinga
  16. Benzinga's Top Initiations

    Benzinga
  17. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  18. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  19. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  22. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  23. Benzinga's Top Pre-Market Gainers

    Benzinga
  24. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  25. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  26. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  27. Benzinga's Top Pre-Market Gainers

    Benzinga
  28. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  29. Benzinga's Top Pre-Market Gainers

    Benzinga
  30. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  31. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  32. Benzinga's Top Pre-Market Losers

    Benzinga
  33. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  34. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  35. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  36. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  37. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  38. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  39. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  40. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  41. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  42. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  43. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  44. A Peek Into The Market Before The Trading Starts

    Benzinga
  45. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  46. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  47. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  48. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  49. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  50. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  51. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
  52. Bank of America Comments on BCRX Phase-3 Data

    Benzinga
  53. BoardCentral StockTalk - weekly update: AAPL, F, MSFT, KERX, ...

    BoardCentral
Trading Center